TDC A/S
TDC and DKT Holdings releases its financial calendar for 2021 as set out below.
9 January
Start of closed period prior to Financial Statements for 2020
5 February
Financial Statements for 2020
8 April
Start of closed period prior to Interim Financial Statements January – March 2021
29 April 2021
Annual Report 2020 public on www.tdcgroup.com
6 May
Interim Financial Statements January – March 2021
8 July
Start of closed period prior to Interim Financial Statements January – June 2021
13 August
Interim Financial Statements January – June 2021
8 October
Start of closed period prior to Interim Financial Statements January – September 2021
5 November
Interim Financial Statements January – September 2021
31 December
End of fiscal year 2021
Release of financial statements for the year and interim financial statements is expected at approximately 9:00 am (CET) on the days referred to.
The closed trading window for persons employed by the TDC Group is 30 days prior to the release of financial statements for the year and interim financial statements.
For inquiries regarding the above please contact TDC Investor Relations on +45 6663 7680 or investorrelations@tdc.dk.
TDC tickers
Reuters TDC.CO.
Bloomberg TDC DC.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
